BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y, Kobayashi M, Hanazaki K. Diagnosis and management of insulinoma. World J Gastroenterol 2013; 19(6): 829-837 [PMID: 23430217 DOI: 10.3748/wjg.v19.i6.829] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 139] [Article Influence: 19.4] [Reference Citation Analysis]
Number Citing Articles
1 Miranda G. Malignant insulinoma chemotherapy resistant, pancreatic neuroendocrine tumor of uncertain prognosis. Journal of Clinical and Translational Endocrinology: Case Reports 2018;8:16-8. [DOI: 10.1016/j.jecr.2018.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Adarsh M, Salman M, Kumar MS, Shetty M. Unusual presentation of an insulinoma in an elderly male patient. J Postgrad Med 2021;67:164-7. [PMID: 34414928 DOI: 10.4103/jpgm.JPGM_1165_20] [Reference Citation Analysis]
3 Mo EY, Lee JY, Kim SY, Kim MJ, Kim ES, Lee S, Han JH, Moon SD. Functional Identification of Compound Heterozygous Mutations in the CYP17A1 Gene Resulting in Combined 17α-Hydroxylase/17,20-Lyase Deficiency. Endocrinol Metab (Seoul) 2018;33:413-22. [PMID: 30229581 DOI: 10.3803/EnM.2018.33.3.413] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Maekawa A, Kudo A, Kishino M, Murase Y, Watanabe S, Ishikawa Y, Ueda H, Akahoshi K, Ogawa K, Ono H, Tanaka S, Kinowaki Y, Tanabe M. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy. J Cancer Res Clin Oncol 2021. [PMID: 33904982 DOI: 10.1007/s00432-021-03650-2] [Reference Citation Analysis]
5 Parisi A, Desiderio J, Cirocchi R, Grassi V, Trastulli S, Barberini F, Corsi A, Cacurri A, Renzi C, Anastasio F, Battista F, Pucci G, Noya G, Schillaci G. Road accident due to a pancreatic insulinoma: a case report. Medicine (Baltimore) 2015;94:e537. [PMID: 25816027 DOI: 10.1097/MD.0000000000000537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
6 Detour J, Pierre A, Boisson F, Kreutter G, Lavaux T, Namer IJ, Kessler L, Brasse D, Marchand P, Imperiale A. Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging. J Nucl Med 2017;58:36-41. [PMID: 27609787 DOI: 10.2967/jnumed.116.180588] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Zaver HB, Alnahhal KI, Ghoz H, Paz-Fumagalli R, Raimondo M, Lukens FJ. Insulinoma: A Recurrent Pancreatic Tumor Amendable to Computed Tomography-Guided Ethanol-Lipiodol Injection. ACG Case Rep J 2021;8:e00539. [PMID: 33654702 DOI: 10.14309/crj.0000000000000539] [Reference Citation Analysis]
8 Antelo G, Hierro C, Fernández JP, Baena E, Bugés C, Layos L, Manzano JL, Caro M, Mesia R. Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents. Drugs Context 2020;9:2020-2-4. [PMID: 32477420 DOI: 10.7573/dic.2020-2-4] [Reference Citation Analysis]
9 Calabrò D, Argalia G, Ambrosini V. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.Diagnostics (Basel). 2020;10. [PMID: 33297381 DOI: 10.3390/diagnostics10121059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Arunraj ST, Damle NA, Bal C, Gupta Y, Pal S. Insulinoma - The incremental value of somatostatin receptor positron emission tomography. Indian J Endocrinol Metab 2017;21:255-6. [PMID: 28217530 DOI: 10.4103/2230-8210.196025] [Reference Citation Analysis]
11 Majid Z, Tahir F, Haider SA. Long-standing Sporadic Pancreatic Insulinoma: Report of a Rare Case. Cureus 2020;12:e6947. [PMID: 32190498 DOI: 10.7759/cureus.6947] [Reference Citation Analysis]
12 Gϋemes M, Rahman SA, Kapoor RR, Flanagan S, Houghton JAL, Misra S, Oliver N, Dattani MT, Shah P. Hyperinsulinemic hypoglycemia in children and adolescents: Recent advances in understanding of pathophysiology and management. Rev Endocr Metab Disord 2020;21:577-97. [PMID: 32185602 DOI: 10.1007/s11154-020-09548-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
13 Tarchouli M, Ali AA, Ratbi MB, Belhamidi Ms, Essarghini M, Aboulfeth el M, Bouzroud M, Sbitti Y, Oukabli M, Elfahssi M, Sair K. Long-standing insulinoma: two case reports and review of the literature. BMC Res Notes 2015;8:444. [PMID: 26374700 DOI: 10.1186/s13104-015-1424-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
14 Li J, Peng J, Tang W, Rawson J, Karunananthan J, Jung M, Ma Y, Shively JE, Kandeel F. Synthesis and evaluation of 18F-PTTCO-Cys40-Exendin-4 for PET imaging of ectopic insulinomas in rodents. Bioorg Chem 2020;98:103718. [PMID: 32171991 DOI: 10.1016/j.bioorg.2020.103718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations. World J Gastroenterol 2020; 26(28): 4036-4054 [PMID: 32821069 DOI: 10.3748/wjg.v26.i28.4036] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
16 de Carbonnières A, Challine A, Cottereau AS, Coriat R, Soyer P, Abou Ali E, Prat F, Terris B, Bertherat J, Dousset B, Gaujoux S. Surgical management of insulinoma over three decades. HPB (Oxford) 2021:S1365-182X(21)00113-1. [PMID: 33975801 DOI: 10.1016/j.hpb.2021.04.013] [Reference Citation Analysis]
17 Filip K, Lewińska A, Adamczyk-Grochala J, Marino Gammazza A, Cappello F, Lauricella M, Wnuk M. 5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma β-TC-6 Cells. Cells 2022;11:1213. [PMID: 35406777 DOI: 10.3390/cells11071213] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
18 Sharma A, Varshney P, Kasliwal R, Nagar A, Venkatatelikicherla K, Sarin S, Choubey RP, Kapoor VK. Insulinoma—Accurate Preoperative Localization Is the Key to Management: An Initial Experience. Indian J Surg Oncol. [DOI: 10.1007/s13193-022-01534-6] [Reference Citation Analysis]
19 Muehler MR, Rendell VR, Bergmann LL, Winslow ER, Reeder SB. Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors. Abdom Radiol (NY) 2021;46:2003-13. [PMID: 33377995 DOI: 10.1007/s00261-020-02883-y] [Reference Citation Analysis]
20 Velikyan I, Eriksson O. Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics. Theranostics 2020;10:437-61. [PMID: 31903131 DOI: 10.7150/thno.38366] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
21 Suzuki K, Kawasaki A, Miyamoto M, Miyamoto T, Kanbayashi T, Sato M, Shimizu T, Hirata K. Insulinoma Masquerading as Rapid Eye Movement Sleep Behavior Disorder: Case Series and Literature Review. Medicine (Baltimore) 2015;94:e1065. [PMID: 26107678 DOI: 10.1097/MD.0000000000001065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
22 Das SS, Thakral P, Manda D, Cb V, Malik D, Sen I. Radioguided Surgery in Insulinoma Using 68Ga Labeled Exendin-4: a Case Report. Nucl Med Mol Imaging 2021;55:253-6. [PMID: 34721718 DOI: 10.1007/s13139-021-00698-3] [Reference Citation Analysis]
23 Fottner C, Ferrata M, Weber MM. Hormone secreting gastro-entero-pancreatic neuroendocrine neoplasias (GEP-NEN): When to consider, how to diagnose? Rev Endocr Metab Disord. 2017;18:393-410. [PMID: 29256148 DOI: 10.1007/s11154-017-9438-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
24 Sun Q, Zhao Z. Peptide Hormones as Tumor Markers in Clinical Practice. Enzymes 2017;42:65-79. [PMID: 29054271 DOI: 10.1016/bs.enz.2017.09.001] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Aydemir E, Ateş C, Mercan Saridaş F, Hocaoğlu E, Cander S, Öz Gül Ö, Ertürk E, Ersoy C. Evaluation of Insulinoma Cases Presented with Hyperinsulinemic Hypoglycemia: A single-centre Experience. Turkish Journal of Internal Medicine. [DOI: 10.46310/tjim.1073351] [Reference Citation Analysis]
26 Yu J, Ping F, Zhang H, Li W, Yuan T, Fu Y, Feng K, Xia W, Xu L, Li Y. Clinical Management of Malignant Insulinoma: a single Institution's experience over three decades. BMC Endocr Disord. 2018;18:92. [PMID: 30522468 DOI: 10.1186/s12902-018-0321-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
27 Nakano Y, Kitago M, Shinoda M, Nakatsuka S, Kurihara I, Yagi H, Abe Y, Oshima G, Hori S, Yokose T, Kitagawa Y. Usefulness of selective arterial calcium injection tests for functional pancreatic neuroendocrine tumors. Sci Rep 2021;11:235. [PMID: 33420290 DOI: 10.1038/s41598-020-80538-0] [Reference Citation Analysis]
28 Thompson R, Landry CS. Multiple endocrine neoplasia 1: a broad overview. Ther Adv Chronic Dis 2021;12:20406223211035288. [PMID: 34413971 DOI: 10.1177/20406223211035288] [Reference Citation Analysis]
29 Kishi K, Kubo K, Tomita T, Nakamura K, Yasui-Furukori N. Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report. Int Med Case Rep J 2019;12:51-4. [PMID: 30863190 DOI: 10.2147/IMCRJ.S200489] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Kwon EB, Jeong HR, Shim YS, Lee HS, Hwang JS. Multiple Endocrine Neoplasia Type 1 Presenting as Hypoglycemia due to Insulinoma. J Korean Med Sci 2016;31:1003-6. [PMID: 27247513 DOI: 10.3346/jkms.2016.31.6.1003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Sugiyama Y, Kiuchi C, Suzuki M, Maruyama Y, Wakabayashi R, Ohno Y, Takahata S, Shibazaki T, Kawamata M. Glucose Management during Insulinoma Resection Using Real-Time Subcutaneous Continuous Glucose Monitoring. Case Rep Anesthesiol 2018;2018:6248467. [PMID: 29977620 DOI: 10.1155/2018/6248467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Dalvi AN, Garale MN, Takalkar YP, Rege SA, Thapar PM, Anurag L, Shah NS. Laparoscopic surgery for solitary insulinoma in the absence of IOUS. J Minim Access Surg 2018;14:9-12. [PMID: 28782747 DOI: 10.4103/jmas.JMAS_6_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Egorov AV, Vasilyev IA, Musayev GH, Mironova AV. The role of microwave ablation in management of functioning pancreatic neuroendocrine tumors. Gland Surg 2019;8:766-72. [PMID: 32042685 DOI: 10.21037/gs.2019.12.07] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Wei J, Liu X, Wu J, Xu W, Gao W, Jiang K, Zhang Z, Miao Y. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbecks Arch Surg 2016;401:1019-25. [PMID: 27539217 DOI: 10.1007/s00423-016-1496-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
35 Shreenivas AV, Leung V. A rare case of insulinoma presenting with postprandial hypoglycemia. Am J Case Rep. 2014;15:488-491. [PMID: 25381469 DOI: 10.12659/ajcr.891336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
36 Ferencz S, Toth D, Kaszas B, Bardosi S, Vicena V, Karadi O, Reglodi D, Kelemen D. PACAP and PAC1 Receptor Expression in Human Insulinomas. Int J Pept Res Ther 2021;27:1719-28. [DOI: 10.1007/s10989-021-10204-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Moreno-Moreno P, Alhambra-Expósito MR, Herrera-Martínez AD, Palomares-Ortega R, Zurera-Tendero L, Espejo Herrero JJ, Gálvez-Moreno MA. Arterial Calcium Stimulation with Hepatic Venous Sampling in the Localization Diagnosis of Endogenous Hyperinsulinism. Int J Endocrinol 2016;2016:4581094. [PMID: 27795707 DOI: 10.1155/2016/4581094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
38 Naples R, Thomas JD, Orabi DA, Reynolds JP, Robertson S, Siperstein AE, Walsh RM, Simon R, Shin JJ, Jin J, Krishnamurthy VD, Berber E. A critical analysis of laparoscopic and open approaches to sporadic pancreatic insulinoma resection in the modern era. Am J Surg 2021:S0002-9610(21)00601-2. [PMID: 34702489 DOI: 10.1016/j.amjsurg.2021.10.011] [Reference Citation Analysis]
39 Fu J, Liu F, Yuan K, Yan J, Wang Y, Zhang J, Yuan B, Wang M. The Value of Hybrid Angio-CT in Preoperative Detection and Localization of Insulinomas: A Single-Center Retrospective Study. Cardiovasc Intervent Radiol 2018;41:633-8. [PMID: 29167968 DOI: 10.1007/s00270-017-1847-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
40 Meier E, Winnicka L, Lau M, Vo D, Joutovsky A, Shenoy MA. Ketogenic Weight Loss Diet Rapidly Unmasks an Insulinoma. Case Rep Endocrinol 2019;2019:9674245. [PMID: 31772788 DOI: 10.1155/2019/9674245] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Yi J, Yang X, Zheng L, Yang G, Sun L, Bao Y, Wu Y, Huang Y, Yu C, Yang SN, Li Y. Photoactivation of hypericin decreases the viability of RINm5F insulinoma cells through reduction in JNK/ERK phosphorylation and elevation of caspase-9/caspase-3 cleavage and Bax-to-Bcl-2 ratio. Biosci Rep 2015;35:e00195. [PMID: 26182357 DOI: 10.1042/BSR20150028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
42 Yuan T, Liu S, Zhu C, Dong Y, Zhu H, Wu X, Tang Y, Zhao W. Continuous Glucose Monitoring in Patients With Insulinoma Treated by Endoscopic Ultrasound-Guided Ethanol Injection. Pancreas 2021;50:183-8. [PMID: 33560091 DOI: 10.1097/MPA.0000000000001735] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Shah P, Rahman SA, Demirbilek H, Güemes M, Hussain K. Hyperinsulinaemic hypoglycaemia in children and adults. The Lancet Diabetes & Endocrinology 2017;5:729-42. [DOI: 10.1016/s2213-8587(16)30323-0] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 10.6] [Reference Citation Analysis]
44 Simó-servat A, Puig de la Bellacasa Suils J, Pérez Maraver M. Hypoglycemia caused by insulinoma. A review of a case series treated at a tertiary hospital. Revista Clínica Española (English Edition) 2018;218:321-2. [DOI: 10.1016/j.rceng.2018.03.007] [Reference Citation Analysis]
45 Mejía D, Contreras R, Molina G, Alcántara M. Altered behavior with an organic cause: a case report. J Med Case Rep 2019;13:192. [PMID: 31234935 DOI: 10.1186/s13256-019-2112-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Caliri M, Verdiani V, Mannucci E, Briganti V, Landoni L, Esposito A, Burato G, Rotella CM, Mannelli M, Peri A. A case of malignant insulinoma responsive to somatostatin analogs treatment. BMC Endocr Disord 2018;18:98. [PMID: 30591061 DOI: 10.1186/s12902-018-0325-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
47 Doi S, Yamada T, Kito Y, Obara S, Fujii Y, Nishimura T, Kato T, Nakayama H, Tsutsumi M, Okamura R. Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking Insulinoma. J Endocr Soc 2022;6:bvab185. [PMID: 35024540 DOI: 10.1210/jendso/bvab185] [Reference Citation Analysis]
48 Borazan E, Aytekin A, Yilmaz L, Elci M, Karaca MS, Kervancioglu S, Balik AA. Multifocal Insulinoma in Pancreas and Effect of Intraoperative Ultrasonography. Case Rep Surg 2015;2015:375124. [PMID: 26295000 DOI: 10.1155/2015/375124] [Reference Citation Analysis]
49 Boss M, Bos D, Frielink C, Sandker G, Bronkhorst P, van Lith SAM, Brom M, Buitinga M, Gotthardt M. Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions. J Nucl Med 2020;61:1588-93. [PMID: 32385165 DOI: 10.2967/jnumed.119.238998] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Wei G, Wang L, Wan X, Tan Y. [ELF4 promotes proliferation and inhibits apoptosis of human insulinoma cells by activating Akt signaling]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:1329-33. [PMID: 34658346 DOI: 10.12122/j.issn.1673-4254.2021.09.06] [Reference Citation Analysis]
51 Subramani S, Bellizzi AM, Borcherding N, Kao SC, Dillon J, Howe J, Norris AW, Tansey MJ, Pinnaro CT. Hypoglycemia secondary to insulinoma masking the onset of type 1 diabetes in an adolescent. Clin Case Rep 2021;9:e04868. [PMID: 34594558 DOI: 10.1002/ccr3.4868] [Reference Citation Analysis]
52 Ambrosini V, Campana D, Nanni C, Marzola MC, Rubello D, Fanti S. 68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. Clinical Nuclear Medicine 2015;40:e132-3. [DOI: 10.1097/rlu.0000000000000447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
53 Spada F, Rossi RE, Kara E, Laffi A, Massironi S, Rubino M, Grimaldi F, Bhoori S, Fazio N. Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management. Pharmaceuticals (Basel) 2021;14:539. [PMID: 34199977 DOI: 10.3390/ph14060539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 McComb K, Roulston G, Armstrong L. Insulinoma: an uncommon cause of delirium. Age Ageing 2022;51:afac055. [PMID: 35305086 DOI: 10.1093/ageing/afac055] [Reference Citation Analysis]
55 Alyusuf EY, Ekhzaimy AA, Rivera JA. Radiofrequency Ablation as a Primary Therapy for Benign Functioning Insulinoma. AACE Clin Case Rep 2021;7:153-7. [PMID: 34095476 DOI: 10.1016/j.aace.2020.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Chandra A, Hati A. Endoscopic ultrasound: a very important tool in detecting small insulinomas. QJM 2022;115:308-9. [PMID: 35266542 DOI: 10.1093/qjmed/hcac071] [Reference Citation Analysis]
57 Antelmi E, Lippolis M, Biscarini F, Tinazzi M, Plazzi G. REM sleep behavior disorder: Mimics and variants. Sleep Med Rev 2021;60:101515. [PMID: 34186416 DOI: 10.1016/j.smrv.2021.101515] [Reference Citation Analysis]
58 O'Donohoe RL, Patel S, Bryant TJC, Stedman B, Hamady Z, Takhar AS, Modi S. Transarterial Embolization for Mitigation of Severe Hypoglycemia in 2 Patients with Primary Pancreatic Insulinoma. J Vasc Interv Radiol 2019;30:476-9. [PMID: 30819499 DOI: 10.1016/j.jvir.2018.10.032] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Iqbal A, Broome DT, Makin V, Yogi-Morren D. Insulinoma With Concomitant Insulin Antibodies. AACE Clin Case Rep 2021;7:247-8. [PMID: 34307846 DOI: 10.1016/j.aace.2021.01.009] [Reference Citation Analysis]
60 Zhao K, Patel N, Kulkarni K, Gross JS, Taslakian B. Essentials of Insulinoma Localization with Selective Arterial Calcium Stimulation and Hepatic Venous Sampling. J Clin Med 2020;9:E3091. [PMID: 32992761 DOI: 10.3390/jcm9103091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Effraimidis G, Knigge U, Rossing M, Oturai P, Rasmussen ÅK, Feldt-Rasmussen U. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs). Semin Cancer Biol 2021:S1044-579X(21)00112-7. [PMID: 33905872 DOI: 10.1016/j.semcancer.2021.04.011] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
62 Buishand FO, Arkesteijn GJ, Feenstra LR, Oorsprong CW, Mestemaker M, Starke A, Speel EJ, Kirpensteijn J, Mol JA. Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. Stem Cells Dev 2016;25:826-35. [PMID: 27049037 DOI: 10.1089/scd.2016.0032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
63 Kajiwara K, Yamagami T, Toyota N, Kakizawa H, Urashima M, Hieda M, Baba Y, Akita T, Tanaka J, Awai K. New Diagnostic Criteria for the Localization of Insulinomas with the Selective Arterial Calcium Injection Test: Decision Tree Analysis. Journal of Vascular and Interventional Radiology 2018;29:1749-53. [DOI: 10.1016/j.jvir.2018.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Qin SY, Lu XP, Jiang HX. EUS-guided ethanol ablation of insulinomas: case series and literature review. Medicine (Baltimore). 2014;93:e85. [PMID: 25255024 DOI: 10.1097/md.0000000000000085] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
65 Coss P, Gilman O, Warren-Smith C, Major AC. The appearance of canine insulinoma on dual phase computed tomographic angiography. J Small Anim Pract 2021;62:540-6. [PMID: 33769568 DOI: 10.1111/jsap.13336] [Reference Citation Analysis]
66 Sood A, Basher RK, Kang M, Shukla J, Behera A, Walia R, Nada R, Mittal BR, Bhattacharya A. 68Ga-DOTA-Exendin PET-MRI Fusion Imaging in a Case of Insulinoma. Clin Nucl Med 2019;44:e428-30. [PMID: 31107750 DOI: 10.1097/RLU.0000000000002620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Lee DW, Kim MK, Kim HG. Diagnosis of Pancreatic Neuroendocrine Tumors. Clin Endosc. 2017;50:537-545. [PMID: 29207856 DOI: 10.5946/ce.2017.131] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
68 Tsang YP, Lang BH, Shek TW. Assessing the short- and long-term outcomes after resection of benign insulinoma. ANZ J Surg 2016;86:706-10. [PMID: 25345822 DOI: 10.1111/ans.12891] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
69 Zhou W, Gong L, Li X, Wan Y, Wang X, Li H, Jiang B. Screening key candidate genes and pathways involved in insulinoma by microarray analysis. Medicine (Baltimore) 2018;97:e10826. [PMID: 29851790 DOI: 10.1097/MD.0000000000010826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
70 Prídavková D, Samoš M, Kyčina R, Adamicová K, Kalman M, Belicová M, Mokáň M. Insulinoma presenting with postprandial hypoglycemia and a low body mass index: A case report. World J Clin Cases 2020; 8(18): 4169-4176 [PMID: 33024775 DOI: 10.12998/wjcc.v8.i18.4169] [Reference Citation Analysis]
71 Nakamura Y, Matsushita A, Katsuno A, Yamahatsu K, Sumiyoshi H, Mizuguchi Y, Uchida E. Clinical outcomes of 15 consecutive patients who underwent laparoscopic insulinoma resection: The usefulness of monitoring intraoperative blood insulin during laparoscopic pancreatectomy. Asian J Endosc Surg 2015;8:303-9. [PMID: 25869736 DOI: 10.1111/ases.12187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
72 Orabona R, Zanardini C, Lojacono A, Zatti S, Cappelli C, Tiberio GA, Villanacci V, Sartori E. Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review. Eur J Case Rep Intern Med 2020;7:001556. [PMID: 32309265 DOI: 10.12890/2020_001556] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
73 Johansen NJ, Christensen MB. A Systematic Review on Insulin Overdose Cases: Clinical Course, Complications and Treatment Options. Basic Clin Pharmacol Toxicol 2018;122:650-9. [PMID: 29316226 DOI: 10.1111/bcpt.12957] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
74 Winston KY, Dawrant J. A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status. J Pediatr Endocrinol Metab 2014;27:773-6. [PMID: 24756045 DOI: 10.1515/jpem-2013-0353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Siddiqui M, Vora A, Ali S, Abramowitz J, Mirfakhraee S. Pasireotide: A Novel Treatment for Tumor-Induced Hypoglycemia Due to Insulinoma and Non-Islet Cell Tumor Hypoglycemia. J Endocr Soc 2021;5:bvaa171. [PMID: 33294765 DOI: 10.1210/jendso/bvaa171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 He M, Wang X, Xu J, Li J, Chang X, Zins M, Jin Z, Xue H. Diffuse Involvement of Pancreas is not Always Autoimmune Pancreatitis. Acad Radiol 2022:S1076-6332(22)00063-0. [PMID: 35279380 DOI: 10.1016/j.acra.2022.01.013] [Reference Citation Analysis]
77 Hedberg F, Pilo C, Wikner J, Törring O, Calissendorff J. Three Sisters With Heterozygous Gene Variants of CYP24A1: Maternal Hypercalcemia, New-Onset Hypertension, and Neonatal Hypoglycemia. J Endocr Soc 2019;3:387-96. [PMID: 30729229 DOI: 10.1210/js.2018-00337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J. Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT. Clin Nucl Med 2020;45:519-24. [PMID: 32453080 DOI: 10.1097/RLU.0000000000003093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
79 Fani M, Peitl PK, Velikyan I. Current Status of Radiopharmaceuticals for the Theranostics of Neuroendocrine Neoplasms. Pharmaceuticals (Basel) 2017;10:E30. [PMID: 28295000 DOI: 10.3390/ph10010030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
80 de Albuquerque Neto CC, da Silva Lira N, Albuquerque MARC, Santa-Cruz F, de França M Vasconcelos L, Ferraz ÁAB, Costa AC. Surgical resection of pancreatic insulinoma during pregnancy: Case report and literature review. Int J Surg Case Rep 2019;61:119-22. [PMID: 31357102 DOI: 10.1016/j.ijscr.2019.07.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
81 Hasanov R, Samadov E, Bayramov N, Ünlü A, Petrone P. Surgical management of insulinomas at the Azerbaijan Medical University: a retrospective study of 21 cases over a 10-year period. Turk J Med Sci 2020;50:1262-9. [PMID: 32394681 DOI: 10.3906/sag-2001-150] [Reference Citation Analysis]
82 Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther 2018;18:837-60. [PMID: 29973077 DOI: 10.1080/14737140.2018.1496822] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
83 Maher MD, Desai DN, Bajaj M. Metastatic insulinoma presenting with post-prandial hypoglycemia. AACE Clinical Case Reports 2022. [DOI: 10.1016/j.aace.2022.03.002] [Reference Citation Analysis]
84 Maggio I, Mollica V, Brighi N, Lamberti G, Manuzzi L, Ricci AD, Campana D. The functioning side of the pancreas: a review on insulinomas. J Endocrinol Invest 2020;43:139-48. [DOI: 10.1007/s40618-019-01091-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
85 Kandaswamy L, Raghavan R, Pappachan JM. Spontaneous hypoglycemia: diagnostic evaluation and management. Endocrine 2016;53:47-57. [PMID: 26951054 DOI: 10.1007/s12020-016-0902-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
86 Jansen TJP, van Lith SAM, Boss M, Brom M, Joosten L, Béhé M, Buitinga M, Gotthardt M. Exendin-4 analogs in insulinoma theranostics. J Labelled Comp Radiopharm 2019;62:656-72. [PMID: 31070270 DOI: 10.1002/jlcr.3750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
87 Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G, Klöppel G. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103:153-171. [PMID: 26742109 DOI: 10.1159/000443171] [Cited by in Crossref: 724] [Cited by in F6Publishing: 582] [Article Influence: 120.7] [Reference Citation Analysis]
88 Ausania F, Senra Del Rio P. Lymphadenectomy in pancreatic neuroendocrine neoplasms: Why are we still debating? Pancreatology 2018;18:855-61. [PMID: 30253923 DOI: 10.1016/j.pan.2018.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
89 de Sousa Lages A, Paiva I, Oliveira P, Portela F, Carrilho F. Endoscopic ultrasound-guided ethanol ablation therapy for pancreatic insulinoma: an unusual strategy. Endocrinol Diabetes Metab Case Rep 2017;2017:16-0145. [PMID: 28458908 DOI: 10.1530/EDM-16-0145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
90 Su AP, Ke NW, Zhang Y, Liu XB, Hu WM, Tian BL, Zhang ZD. Is laparoscopic approach for pancreatic insulinomas safe? Results of a systematic review and meta-analysis. J Surg Res. 2014;186:126-134. [PMID: 23992857 DOI: 10.1016/j.jss.2013.07.051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
91 Adelmeyer J, Göbel F, Kann PH. Is the Size of Insulinoma Predictive for its Endocrine Behavior? An Endoscopic Ultrasound Study. Exp Clin Endocrinol Diabetes 2022. [PMID: 35500603 DOI: 10.1055/a-1840-7492] [Reference Citation Analysis]
92 Frey S, Mirallié E, Le Bras M, Regenet N. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers (Basel) 2021;13:5954. [PMID: 34885063 DOI: 10.3390/cancers13235954] [Reference Citation Analysis]
93 Ng HY, Pape A. Insulinoma: important in the differential diagnosis of persistent hypoglycaemia unrelated to diabetes. Med J Aust 2018;208:157-8. [PMID: 29490216 DOI: 10.5694/mja17.00174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Yadav RS, Pokharel A, Gaire D, Shrestha S, Pokharel A, Pradhan S, Kansakar PBS. Multiple Endocrine Neoplasia Type 1 with Concomitant Existence of Malignant Insulinoma: A Rare Finding. Case Rep Endocrinol 2021;2021:8842667. [PMID: 34367700 DOI: 10.1155/2021/8842667] [Reference Citation Analysis]
95 Xu Q, Zhu C, Xu Y, Pan D, Liu P, Yang R, Wang L, Chen F, Sun X, Luo S. Preliminary evaluation of [(18)F]AlF-NOTA-MAL-Cys(39)-exendin-4 in insulinoma with PET. J Drug Target. 2015;23:813-820. [PMID: 25758750 DOI: 10.3109/1061186x.2015.1020808] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
96 Chen OT, Dojki FK, Weber SM, Hinshaw JL. Percutaneous Microwave Ablation of an Insulinoma in a Patient with Refractory Symptomatic Hypoglycemia. J Gastrointest Surg 2015;19:1378-81. [PMID: 25941027 DOI: 10.1007/s11605-015-2831-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
97 England RW, Geer EB, Deipolyi AR. Role of Venous Sampling in the Diagnosis of Endocrine Disorders. J Clin Med 2018;7:E114. [PMID: 29757946 DOI: 10.3390/jcm7050114] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
98 Zhang P, Zhao Z, Zhang L, Wu W, Xu Y, Pan D, Wang F, Yang M. [68Ga]Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of insulinoma. Nucl Med Biol 2019;74-75:19-24. [PMID: 31450071 DOI: 10.1016/j.nucmedbio.2019.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
99 Chen PH, Wang JS, Hwang JI, Lin SY, Sheu WH, Wu YJ, Peng CM, Lee IT. Insulinoma in a young female patient with systemic lupus erythematosus: a case report. Endocr Pract 2014;20:e256-9. [PMID: 25148817 DOI: 10.4158/EP14181.CR] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Chen Q, Wang WJ, Jia YX, Yuan H, Wu PF, Ge WL, Meng LD, Huang XM, Shen P, Yang TY, Miao Y, Zhang JJ, Jiang KR. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell Biosci 2021;11:86. [PMID: 33985581 DOI: 10.1186/s13578-021-00602-8] [Reference Citation Analysis]
101 Foppiani L, Panarello S, Filauro M, Scirocco MC, Cappato S, Parodi A, Sola S, Antonucci G. Insulinoma and Chronic Kidney Disease: An Uncommon Conundrum Not to Be Overlooked. Clin Med Insights Endocrinol Diabetes 2017;10:1179551417742620. [PMID: 29200897 DOI: 10.1177/1179551417742620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
102 Atsawarungruangkit A, Chenbhanich J, Dickstein G. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population. World J Gastroenterol 2018; 24(32): 3663-3670 [PMID: 30166861 DOI: 10.3748/wjg.v24.i32.3663] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
103 Wei W, Ehlerding EB, Lan X, Luo QY, Cai W. Molecular imaging of β-cells: diabetes and beyond. Adv Drug Deliv Rev 2019;139:16-31. [PMID: 31378283 DOI: 10.1016/j.addr.2018.06.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
104 Bor R, Farkas K, Bálint A, Molnár T, Nagy F, Valkusz Z, Sepp K, Tiszlavicz L, Hamar S, Szepes Z. [Endoscopic ultrasound-guided ethanol ablation: an alternative option for the treatment of pancreatic insulinoma]. Orv Hetil. 2014;155:1647-1651. [PMID: 25282110 DOI: 10.1556/oh.2014.30012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
105 Ueda K, Taira T, Hakoda H, Nakata S, Okata S, Nagai T, Aoki S, Mishima H, Sako A, Maruyama T, Okumura M. Giant insulinoma: report of a case and review of published reports. Surg Case Rep 2016;2:136. [PMID: 27864816 DOI: 10.1186/s40792-016-0265-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
106 Guilmette JM, Nosé V. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances. Adv Anat Pathol 2019;26:13-30. [PMID: 29912000 DOI: 10.1097/PAP.0000000000000201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 13.7] [Reference Citation Analysis]
107 Riechelmann RP, Weschenfelder RF, Costa FP, Andrade AC, Osvaldt AB, Quidute AR, Dos Santos A, Hoff AA, Gumz B, Buchpiguel C, Vilhena Pereira BS, Lourenço Junior DM, da Rocha Filho DR, Fonseca EA, Riello Mello EL, Makdissi FF, Waechter FL, Carnevale FC, Coura-Filho GB, de Paulo GA, Girotto GC, Neto JE, Glasberg J, Casali-da-Rocha JC, Rego JF, de Meirelles LR, Hajjar L, Menezes M, Bronstein MD, Sapienza MT, Fragoso MC, Pereira MA, Barros M, Forones NM, do Amaral PC, de Medeiros RS, Araujo RL, Bezerra RO, Peixoto RD, Aguiar S Jr, Ribeiro U Jr, Pfiffer T, Hoff PM, Coutinho AK. Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group. Ecancermedicalscience 2017;11:716. [PMID: 28194228 DOI: 10.3332/ecancer.2017.716] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
108 Senica K, Tomazic A, Skvarca A, Kolenc Peitl P, Mikolajczak R, Hubalewska-dydejczyk A, Lezaic L. Superior Diagnostic Performance of the GLP-1 Receptor Agonist [Lys40(AhxHYNIC-[99mTc]/EDDA)NH2]-Exendin-4 over Conventional Imaging Modalities for Localization of Insulinoma. Mol Imaging Biol 2020;22:165-72. [DOI: 10.1007/s11307-019-01372-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
109 Grimaldi F, Fazio N, Attanasio R, Frasoldati A, Papini E, Angelini F, Baldelli R, Berretti D, Bianchetti S, Bizzarri G, Caputo M, Castello R, Cremonini N, Crescenzi A, Davì MV, D'Elia AV, Faggiano A, Pizzolitto S, Versari A, Zini M, Rindi G, Oberg K. Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J Endocrinol Invest 2014;37:875-909. [PMID: 25038902 DOI: 10.1007/s40618-014-0119-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
110 Varela D, Yu A, Saxon D. Insulinoma Masquerading as Transient Neurocognitive Impairment. Am J Med 2018;131:e377-9. [PMID: 29753794 DOI: 10.1016/j.amjmed.2018.04.031] [Reference Citation Analysis]
111 Lo CH, Sun DP. A case of low serum insulin levels in a patient with insulinoma. Endocrinol Diabetes Metab Case Rep 2016;2016:16-0041. [PMID: 27555915 DOI: 10.1530/EDM-16-0041] [Reference Citation Analysis]
112 Furnica RM, Istasse L, Maiter D. A severe but reversible reduction in insulin sensitivity is observed in patients with insulinoma. Ann Endocrinol (Paris) 2018;79:30-6. [PMID: 29241949 DOI: 10.1016/j.ando.2017.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
113 Solomou S, Khan R, Propper D, Berney D, Druce M. A case of insulin and ACTH co-secretion by a neuroendocrine tumour. Endocrinol Diabetes Metab Case Rep 2014;2014:130082. [PMID: 24683485 DOI: 10.1530/EDM-13-0082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Buishand FO, Visser J, Kik M, Gröne A, Keesler RI, Briaire-de Bruijn IH, Kirpensteijn J. Evaluation of prognostic indicators using validated canine insulinoma tissue microarrays. The Veterinary Journal 2014;201:57-63. [DOI: 10.1016/j.tvjl.2014.05.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
115 Song P, Yan JY, Wang Y, Li X. Value of multi-detector computed tomography during intra-arterial infusion of contrast medium for locating insulinomas. J Int Med Res 2020;48:300060519889432. [PMID: 32212878 DOI: 10.1177/0300060519889432] [Reference Citation Analysis]
116 Bongetti E, Lee MH, Pattison DA, Hicks RJ, Norris R, Sachithanandan N, MacIsaac RJ. Diagnostic challenges in a patient with an occult insulinoma:68 Ga-DOTA-exendin-4 PET/CT and 68Ga-DOTATATE PET/CT. Clin Case Rep 2018;6:719-22. [PMID: 29636947 DOI: 10.1002/ccr3.1448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
117 Gezer E, Çetinarslan B, Karakaya D, Cantürk Z, Selek A, Sözen M, İşgören S. Differentiation of insulinoma from accessory spleen by 99mTc-labelled heat-denaturated red blood cell scintigraphy: case report. BMC Endocr Disord 2021;21:6. [PMID: 33413309 DOI: 10.1186/s12902-020-00671-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Javed AA, Hasanain A, Haider A, Jones G, Javed ZN, Soares K, Burkhart RA, Cameron JL, Weiss MJ, Wolfgang CL, He J. Clinicopathological features and surgical outcomes of resected functional pancreatic neuroendocrine tumors: a single institution experience. Journal of Pancreatology 2019;2:29-34. [DOI: 10.1097/jp9.0000000000000018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
119 Dobrindt EM, Mogl M, Goretzki PE, Pratschke J, Dukaczewska AK. Insulinoma in pregnancy (a case presentation and systematic review of the literature). Rare Tumors 2021;13:2036361320986647. [PMID: 33613925 DOI: 10.1177/2036361320986647] [Reference Citation Analysis]
120 Yang Y, Shi J, Zhu J. Diagnostic performance of noninvasive imaging modalities for localization of insulinoma: A meta-analysis. Eur J Radiol 2021;145:110016. [PMID: 34763145 DOI: 10.1016/j.ejrad.2021.110016] [Reference Citation Analysis]
121 Munro V, McDonell LM, Keough V, Siddiqi FS. Insulinoma presenting as hypoglycemia during lactose tolerance testing: a case report. J Med Case Rep 2020;14:96. [PMID: 32605595 DOI: 10.1186/s13256-020-02419-4] [Reference Citation Analysis]
122 Saloustros E, Salpea P, Starost M, Liu S, Faucz FR, London E, Szarek E, Song WJ, Hussain M, Stratakis CA. Prkar1a gene knockout in the pancreas leads to neuroendocrine tumorigenesis. Endocr Relat Cancer 2017;24:31-40. [PMID: 27803029 DOI: 10.1530/ERC-16-0443] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
123 Jyotsna VP, Pal S, Kandasamy D, Gamanagatti S, Garg PK, Raizada N, Sahni P, Bal CS, Tandon N, Ammini AC. Evolving management of insulinoma: Experience at a tertiary care centre. Indian J Med Res 2016;144:771. [PMID: 28361831 DOI: 10.4103/ijmr.IJMR_1477_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 Jalilian R, Mirza L, Blackett PR. A Case of 36-Year-Old Woman With Recurrent Hypoglycemia Due to Insulinoma With Cytokeratin-19 Expression: A Marker of Poor Prognosis. Pancreas 2016;45:e3-4. [PMID: 26752258 DOI: 10.1097/MPA.0000000000000492] [Reference Citation Analysis]
125 Miron I, Diaconescu S, Aprodu G, Ioniuc I, Diaconescu MR, Miron L. Diagnostic Difficulties in a Pediatric Insulinoma: A Case Report.Medicine (Baltimore). 2016;95:e3045. [PMID: 26986124 DOI: 10.1097/MD.0000000000003045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
126 Antonakis PT, Ashrafian H, Martinez-Isla A. Pancreatic insulinomas: Laparoscopic management. World J Gastrointest Endosc 2015; 7(16): 1197-1207 [PMID: 26566426 DOI: 10.4253/wjge.v7.i16.1197] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
127 El Sayed G, Frim L, Franklin J, McCrudden R, Gordon C, Al-Shamma S, Kiss S, Hegyi P, Erőss B, Hegyi PJ. Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review. Therap Adv Gastroenterol 2021;14:17562848211042171. [PMID: 34819995 DOI: 10.1177/17562848211042171] [Reference Citation Analysis]
128 Streit L, Brunaud L, Vitale N, Ory S, Gasman S. Hormones Secretion and Rho GTPases in Neuroendocrine Tumors. Cancers (Basel) 2020;12:E1859. [PMID: 32664294 DOI: 10.3390/cancers12071859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Worth C, Dunne M, Ghosh A, Harper S, Banerjee I. Continuous glucose monitoring for hypoglycaemia in children: Perspectives in 2020. Pediatr Diabetes 2020;21:697-706. [PMID: 32315515 DOI: 10.1111/pedi.13029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
130 Câmara-de-Souza AB, Toyoshima MTK, Giannella ML, Freire DS, Camacho CP, Lourenço DM Jr, Rocha MS, Bacchella T, Jureidini R, Machado MCC, Almeida MQ, Pereira MAA. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors. Pancreatology 2018;18:298-303. [PMID: 29452754 DOI: 10.1016/j.pan.2018.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
131 Jung SY, Kang B, Choi YM, Kim JM, Kim SK, Kwon YS, Lee JE. Development of multifocal nodular lesions of a liver mimicking hepatic metastasis, following resection of an insulinoma in a child. Korean J Pediatr 2015;58:69-72. [PMID: 25774199 DOI: 10.3345/kjp.2015.58.2.69] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
132 Sun M, Luo Y, You Y, Han X, Zhao Y, Han X, Zhao Y. Ectopic insulinoma: case report. BMC Surg 2019;19:197. [PMID: 31852474 DOI: 10.1186/s12893-019-0661-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
133 Capodanno Y, Altieri B, Elders R, Colao A, Faggiano A, Schrader J. Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies. Transl Oncol 2021;15:101269. [PMID: 34794032 DOI: 10.1016/j.tranon.2021.101269] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Singbo J, Locketz M, Ross IL. Challenge of coexisting type 2 diabetes mellitus and insulinoma: a case report. J Med Case Rep 2021;15:479. [PMID: 34583764 DOI: 10.1186/s13256-021-03047-2] [Reference Citation Analysis]
135 Asban A, Patel AJ, Reddy S, Wang T, Balentine CJ, Chen H. Cancer of the Endocrine System. Abeloff's Clinical Oncology. Elsevier; 2020. pp. 1074-1107.e11. [DOI: 10.1016/b978-0-323-47674-4.00068-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Halpin K, McDonough R, Alba P, Halpin J, Singh V, Yan Y. Vague neuroglycopenic complaints camouflage diagnosis of adolescent insulinoma: a case report. Int J Pediatr Endocrinol 2016;2016:14. [PMID: 27478444 DOI: 10.1186/s13633-016-0032-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
137 Scharf M, Mueller D, Koenig U, Pfestroff A, Nimphius W, Figiel J, Rinke A, Koenig A, Gress T. Management of a metastasized high grade insulinoma (G3) with refractory hypoglycemia: Case report and review of the literature. Pancreatology 2014;14:542-5. [DOI: 10.1016/j.pan.2014.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
138 Leroy-freschini B, Amodru V, Addeo P, Sebag F, Vix M, Brunaud L, Klein M, Bahougne T, Bachellier P, Castinetti F, Goichot B, Chevalier E, Taieb D, Imperiale A. Early 18F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma. Eur J Nucl Med Mol Imaging 2019;46:686-95. [DOI: 10.1007/s00259-018-4245-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
139 Garrido S, Amado A, Costa F, Soares P, Bacelar C, Amaral C. Insulinoma in a Patient with Type 2 Diabetes: A Case Report. AACE Clinical Case Reports 2016;2:e342-5. [DOI: 10.4158/ep151129.cr] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
140 Mîndrescu NM, Văcaru G, Guja L, Miulescu RED. Uncommon Manifestation of Hypoglycemia in a Patient with Insulinoma – A Case Report. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2019;26:327-30. [DOI: 10.2478/rjdnmd-2019-0035] [Reference Citation Analysis]
141 Rouland A, Bouillet B, Legris P, Simoneau I, Petit JM, Vergès B. Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion. Clin Pharmacol 2021;13:33-7. [PMID: 33574715 DOI: 10.2147/CPAA.S278978] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Kim S, Conrad M, Chuang E, Cai L, Masharani U, Murphy EJ. Calcium Stimulation Test for Insulinoma Localization in an End-stage Renal Disease Patient on Diazoxide. J Endocr Soc 2021;5:bvaa185. [PMID: 33381673 DOI: 10.1210/jendso/bvaa185] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
143 Dudum R, Murthy VK. Keeping a Low Profile: Insulinoma. Am J Med 2019;132:1160-2. [PMID: 31054830 DOI: 10.1016/j.amjmed.2019.04.017] [Reference Citation Analysis]
144 Lobaton-Ginsberg M, Sotelo-González P, Ramirez-Renteria C, Juárez-Aguilar FG, Ferreira-Hermosillo A. Insulinoma after sleeve gastrectomy: A case report. World J Clin Cases 2022; 10(18): 6227-6233 [DOI: 10.12998/wjcc.v10.i18.6227] [Reference Citation Analysis]
145 Cigrovski Berkovic M, Ulamec M, Marinovic S, Balen I, Mrzljak A. Malignant insulinoma: Can we predict the long-term outcomes? World J Clin Cases 2022; 10(16): 5124-5132 [DOI: 10.12998/wjcc.v10.i16.5124] [Reference Citation Analysis]